论文部分内容阅读
作为慢性心力衰竭的治疗药物,已经证明可以改善预后和QOL的药物有:ACE抑制剂、ATⅡ受体拮抗剂、醛固酮拮抗剂、β受体阻断剂和硝酸酯类药。这些药物分别有独立的治疗效果,根据大规模临床试验获得的证据制成尽可能提高治疗效果的标准治疗方法。但是,不同病例的耐受性和有效性差别很大。因此不应认为治疗效果都优越,还应考虑到多种临床表现和患者对治疗的看法,采取适合病人的个体化诊治方案。
As therapeutic agents for chronic heart failure, drugs that have shown promise for improving outcomes and QOL are ACE inhibitors, AT II receptor antagonists, aldosterone antagonists, β blockers and nitrates. Each of these medications has its own independent treatment and is based on evidence from large-scale clinical trials to produce standard treatments that maximize the effectiveness of the treatment. However, the tolerability and effectiveness of different cases vary greatly. Therefore, the treatment effect should not be considered superior, but also should take into account a variety of clinical manifestations and patient perceptions of treatment, to take individualized diagnosis and treatment programs for patients.